Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study

BACKGROUND: Medications for the treatment of opioid use disorder, such as buprenorphine, are effective and essential for addressing the opioid epidemic. However, high dropout rates from medication remain a challenge. Behavioral treatment with contingency management and cognitive behavioral counselin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawasaki, Sarah, Mills-Huffnagle, Sara, Aydinoglo, Nicole, Maxin, Halley, Nunes, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994143/
https://www.ncbi.nlm.nih.gov/pubmed/35333189
http://dx.doi.org/10.2196/33073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994143/
https://www.ncbi.nlm.nih.gov/pubmed/35333189
http://dx.doi.org/10.2196/33073

Ejemplares similares